Overview
Atrophoderma vermiculata (also known as folliculitis ulerythematosa reticulata, or honeycomb atrophy) is a rare skin condition classified among the keratosis pilaris atrophicans group of disorders. It primarily affects the cheeks, presenting as small, worm-like (vermiculate) pits and depressions in the skin that create a characteristic honeycomb or reticulated pattern of atrophy. The condition typically begins in childhood, often between ages 5 and 12, and results from inflammation and subsequent atrophy of hair follicles in the affected areas. The skin may initially show small keratotic follicular papules with surrounding erythema before progressing to the distinctive pitted scarring. The condition predominantly affects the facial skin, particularly the cheeks, though it can occasionally extend to the preauricular areas, forehead, and ears. The pitted scars are usually symmetric and permanent. Atrophoderma vermiculata can occur as an isolated finding or may be associated with other conditions, including keratosis pilaris on the limbs and trunk. It has been described in association with certain syndromes, and some familial cases suggest a genetic component. There is no definitive cure for atrophoderma vermiculata. Treatment is largely symptomatic and cosmetic. Topical retinoids, keratolytic agents, and emollients have been used with limited success to manage the keratotic component. Procedural interventions such as dermabrasion, laser resurfacing (including fractional CO2 laser and erbium YAG laser), and chemical peels have been attempted to improve the appearance of established atrophic scars, with variable results. Early treatment aimed at reducing follicular inflammation may help limit progression of scarring.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Atrophoderma vermiculata.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Atrophoderma vermiculata at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Atrophoderma vermiculata.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Atrophoderma vermiculata.
Community
No community posts yet. Be the first to share your experience with Atrophoderma vermiculata.
Start the conversation →Latest news about Atrophoderma vermiculata
No recent news articles for Atrophoderma vermiculata.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Atrophoderma vermiculata
What is Atrophoderma vermiculata?
Atrophoderma vermiculata (also known as folliculitis ulerythematosa reticulata, or honeycomb atrophy) is a rare skin condition classified among the keratosis pilaris atrophicans group of disorders. It primarily affects the cheeks, presenting as small, worm-like (vermiculate) pits and depressions in the skin that create a characteristic honeycomb or reticulated pattern of atrophy. The condition typically begins in childhood, often between ages 5 and 12, and results from inflammation and subsequent atrophy of hair follicles in the affected areas. The skin may initially show small keratotic folli
At what age does Atrophoderma vermiculata typically begin?
Typical onset of Atrophoderma vermiculata is childhood. Age of onset can vary across affected individuals.